Apr 11 2019
On March 23, MSCO held a conference on Immuno- Oncology in MGM. Experts from China and Macau were joined and shared their opinions on this hot topic.
Two IO drugs has been licensed in China and patients can get assess to IO treatment more easily than before. However many issues were now became more and more concerned, for example, the optimal combination with cytotoxic agents, and management of IO related side effects.
During this event, doctors from different parts of China talked their experience with IO therapy. We are now posed a new proposal on a guideline for AE managements.